Drug Side Effects
Search
HUMAN PAPILLOMAVIRUS REACTIVATION
HUMAN PAPILLOMAVIRUS REACTIVATION
was reported 13 times
These drug classes are most commonly taken by patients reporting HUMAN PAPILLOMAVIRUS REACTIVATION:
#
Drug
Count
0
Corticosteroid [EPC]
9
1
CD38-directed Cytolytic Antibody [EPC]
7
2
Proteasome Inhibitor [EPC]
7
3
Interleukin-23 Antagonist [EPC]
2
4
Janus Kinase Inhibitor [EPC]
2
5
Integrin Receptor Antagonist [EPC]
1
6
Purine Antimetabolite [EPC]
1